ABCG1 and HDL in Health and Disease

A special issue of Biology (ISSN 2079-7737).

Deadline for manuscript submissions: 2 January 2025 | Viewed by 302

Special Issue Editors

E-Mail Website
Guest Editor
Department of Food, Nutrition, and Packaging Sciences, College of Agriculture, Forestry & Life Sciences, Clemson University, Clemson, SC 29634, USA
Interests: ABCA1; ABCG1; atherosclerosis; cholesterol efflux; miR-33; reverse cholesterol transport

E-Mail Website
Guest Editor
Clemson Light Imaging Facility, Clemson University, Clemson, SC 29634, USA
Interests: biomarker; cell biology; exosome; extracellular vesicle; nanoparticle

Special Issue Information

Dear Colleagues,

Intracellular cholesterol content is crucial to influencing several conditions and disease states, as altering intracellular cholesterol levels impacts membrane fluidity, lipid raft formation/disruption, and signaling pathways. Cellular cholesterol metabolism is regulated by numerous factors and the removal of cellular cholesterol is considered to be primarily controlled by cholesterol efflux. Two major proteins which regulate cholesterol efflux are the transporter ABCG1 and the lipoprotein HDL. However, both of these proteins appear to modulate other biological effects besides the removal of cholesterol. For instance, ABCG1 expression has been shown to be anti-inflammatory, and HDL is considered to have both antioxidant and anti-inflammatory properties. Interestingly, while HDL is largely thought to be atheroprotective, some data suggest certain HDL particles may be harmful to health. Moreover, it is not entirely elucidated whether the biological effects that ABCG1 and HDL exhibit rely entirely on ABCG1/HDL-mediated cholesterol efflux. It is also poorly understood whether ABCG1 expression in certain cells and tissues may either promote health or be a factor in the development of certain diseases.

This Special Issue of Biology welcomes any novel and innovative research articles as well as comprehensive reviews which focus on the impact of ABCG1 and/or HDL in the context of health and disease.

Dr. Alexis Stamatikos
Dr. Terri F. Bruce
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • atherosclerosis
  • cancer
  • cardiovascular disease
  • cholesterol efflux
  • diet-related disease
  • inflammation
  • lipid raft
  • reverse cholesterol transport

Published Papers

This special issue is now open for submission.
Back to TopTop